发明名称 |
USE OF TETRAHYDROBIOPTERIN AS A MARKER AND A THERAPEUTIC AGENT FOR FABRY DISEASE |
摘要 |
<p>Blood and tissue markers of the metabolic status, risk of health complications in Fabry disease patients and as a biomarker to follow the efficacy of treatment in animal models and patients with Fabry disease comprising tetrahydrobiopterin (BH4), precursors and metabolites of BH4, and other related co-factors is disclosed herein. The present invention further describes the use of BH4 therapy as a treatment option for Fabry disease to prevent, slow or reverses vascular cardiac and renal manifestations of Fabry disease.</p> |
申请公布号 |
KR20120022849(A) |
申请公布日期 |
2012.03.12 |
申请号 |
KR20117025920 |
申请日期 |
2010.04.09 |
申请人 |
BAYLOR RESEARCH INSTITUTE |
发明人 |
SCHIFFMANN RAPHAEL;BOTTIGLIERI TEODORO G.;ARNING ERLAND;MOORE DAVID F. |
分类号 |
G01N33/92;A61K31/519;A61P3/00;G01N33/50 |
主分类号 |
G01N33/92 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|